Current Edition

news

5 FDA decisions to watch in the third quarter

The Food and Drug Administration made one of the most controversial decisions in its history early last month, when the agency decided to clear Biogen’s …

Continue Reading →
news

A well-funded cancer drug startup brings on GSK’s Axel Hoos as CEO

Scorpion Therapeutics, a new biotech startup that’s raised $270 million to develop better drugs for cancer, is drawing from big pharma for its next leader, …

Continue Reading →
news

Lilly, Boehringer say diabetes drug first to succeed in hard-to-treat heart failure

Diabetes drugmakers have expended considerable resources proving their medicines can also reduce the risk of cardiovascular death. Lilly and Boehringer Ingelheim’s testing of Jardiance in …

Continue Reading →
news

8 key clinical trials to watch for the rest of 2021

The first half of 2021 was historic for biotech. The Food and Drug Administration cleared the first new Alzheimer’s drug in nearly two decades, a …

Continue Reading →
news

FDA revises labeling of Biogen’s Alzheimer’s drug to emphasize early treatment

The Food and Drug Administration, under heavy criticism over its decision last month to approve Biogen’s Alzheimer’s drug Aduhelm, has revised the medicine’s prescribing information …

Continue Reading →